Patent · US Active

Anti-cancer cycloalkyl diamines

US9345673B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 14, 2015
Grant dateMay 24, 2016
Priority date
Expiry dateJul 14, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to a method of treatment of a cancer, in a mammal, the method comprising administering to said mammal in need of such treatment an effective amount of a cell growth inhibitory compound of formula I or a pharmaceutically acceptable salt form thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.